MS drug
Boards of Appeal revoke Biogen's dosage patent for Tecfidera
The Boards of Appeal at the European Patent Office have refused to grant Biogen's dosage patent EP 873, which is central to its multiple sclerosis dru
...
12 December 2025 by Mathieu Klos
